These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2477573)

  • 21. Effects of pancreastatin on pancreatic hormone secretion in the dog.
    Ribes G; Vecina F; Hillaire-Buys D; Ahren B
    Horm Res; 1990; 33(5):194-8. PubMed ID: 1980260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
    Ahrén B; Bertrand G; Roye M; Ribes G
    Acta Physiol Scand; 1996 Sep; 158(1):63-70. PubMed ID: 8876749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of porcine pancreastatin on endocrine function of canine pancreas.
    Ohneda A; Koizumi F; Ohneda M
    Tohoku J Exp Med; 1989 Dec; 159(4):291-8. PubMed ID: 2699104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer.
    Smith JP; Kramer S; Bagheri S
    Pancreas; 1991 Sep; 6(5):551-7. PubMed ID: 1946312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical identification and effects of atrial natriuretic peptide, pancreastatin, leucine-enkephalin, and galanin in the porcine pancreas.
    Adeghate E; Ember Z; Donáth T; Pallot DJ; Singh J
    Peptides; 1996; 17(3):503-9. PubMed ID: 8735979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivity of human pancreastatin and its localization in pancreas.
    Funakoshi A; Jimi A; Yasunami Y; Tateishi K; Funakoshi S; Tamamura H; Yajima H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):913-8. PubMed ID: 2649103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of pancreatic exocrine secretion in the rat by calcitonin gene-related peptide: involvement of circulating somatostatin.
    Mulholland MW; Garcia R; Garcia I; Taborsky GJ; Helton S
    Endocrinology; 1989 Apr; 124(4):1849-56. PubMed ID: 2466638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas.
    Peiró E; Miralles P; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1989 Jul; 38(7):679-82. PubMed ID: 2661967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture.
    Fasciotto BH; Gorr SU; DeFranco DJ; Levine MA; Cohn DV
    Endocrinology; 1989 Sep; 125(3):1617-22. PubMed ID: 2759035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.
    Holst JJ; Ostenson CG; Harling H; Messell T
    Diabetologia; 1990 Jul; 33(7):403-6. PubMed ID: 1976102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pancreastatin and chromogranin A on insulin release stimulated by various insulinotropic agents.
    Ishizuka J; Tatemoto K; Cohn DV; Thompson JC; Greeley GH
    Regul Pept; 1991 Jun; 34(1):25-32. PubMed ID: 1857778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of glucose-stimulated insulin release in the perfused rat pancreas by parathyroid secretory protein-I (chromogranin-A).
    Greeley GH; Thompson JC; Ishizuka J; Cooper CW; Levine MA; Gorr SU; Cohn DV
    Endocrinology; 1989 Mar; 124(3):1235-8. PubMed ID: 2645112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pirenzepine inhibits pancreatic exocrine secretion in the rat.
    Otsuki M; Okabayashi Y; Oka T; Nakamura T; Fujii M; Baba S
    Pancreas; 1986; 1(5):443-8. PubMed ID: 2436217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
    Shimizu K
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion.
    Miyasaka K; Funakoshi A; Kitani K; Tamamura H; Fujii N; Funakoshi S
    FEBS Lett; 1990 Apr; 263(2):279-80. PubMed ID: 2335229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of inhibition of pancreatic secretion by the beta-adrenergic agonist, terbutaline.
    Joehl RJ
    Pancreas; 1986; 1(3):232-8. PubMed ID: 2437567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreastatin: characterization of biological activity.
    Zhang T; Mochizuki T; Kogire M; Ishizuka J; Yanaihara N; Thompson JC; Greeley GH
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1157-60. PubMed ID: 2268319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pancreastatin on pancreatic endocrine function in the conscious rat.
    Funakoshi A; Miyasaka K; Kitani K; Tatemoto K
    Regul Pept; 1989 Mar; 24(3):225-31. PubMed ID: 2652201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.